Sihuan Pharmaceutical Holdings Group Receivables

Sihuan Pharmaceutical Holdings Group (SHPHF) currently reports a receivables of $2.2B as of June 2026. That compares with $740M in the prior-year period — up 194.3% year over year. Use the charts on this page to explore Sihuan Pharmaceutical Holdings Group's receivables history and peer comparisons.

Sihuan Pharmaceutical Holdings Group's receivables increased from $740M to $2.2B — a 194.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sihuan Pharmaceutical Holdings Group reported $2.2B in receivables as of June 2026. That compares with $740M in the prior-year period — up 194.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $2.2B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sihuan Pharmaceutical Holdings Group, and consider following SHPHF for alerts when major investors trade the stock.